Browse By Oncolytic Virus Species Result Page of OvirusTdb

The Total number of records shown on this page is 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_619ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.001 MOI77% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_620ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.01 MOI77% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_621ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.1 MOI52% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_622ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.5 MOI48% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_623ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay1 MOI40% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_624ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.001 MOI60% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_625ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.01 MOI50% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_626ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.1 MOI48% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_627ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.5 MOI40% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_628ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay1 MOI38% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_629ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_630ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.01 MOI110% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_631ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.1 MOI60% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_632ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.5 MOI40% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_633ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay1 MOI30% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_634ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.001 MOI110% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_635ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.01 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_636ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.1 MOI58% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_637ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.5 MOI25% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_638ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay1 MOI25% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_639ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.001 MOI105% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_640ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.01 MOI107% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_641ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.1 MOI90% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_642ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.5 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_643ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay1 MOI61% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_644ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.001 MOI90% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_645ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.01 MOI93% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_646ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.1 MOI87% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_647ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.5 MOI58% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_648ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay1 MOI59% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_649ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.001 MOI111% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_650ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.01 MOI102% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_651ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.1 MOI98% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_652ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.5 MOI75% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_653ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay1 MOI50% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_654ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.001 MOI106% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_655ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.01 MOI95% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_656ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.1 MOI89% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_657ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.5 MOI39% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_658ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay1 MOI40% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_659ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.001 MOI100% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_660ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.01 MOI96% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_661ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.1 MOI92% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_662ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.5 MOI92% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_663ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay1 MOI90% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_664ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.001 MOI88% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_665ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.01 MOI94% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_666ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.1 MOI90% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_667ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.5 MOI91% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_668ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (antagonism)NoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay1 MOI88% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_669ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.001 MOI98% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_670ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.01 MOI78% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_671ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.1 MOI60% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_672ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.5 MOI20% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_673ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 3 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay1 MOI12% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_674ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.001 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_675ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.01 MOI60% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_676ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.1 MOI17% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_677ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.5 MOI8% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_678ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 5 Gy (synergism)NoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay1 MOI8% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_679ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to mock-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_680ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.01 MOI105% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_681ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.1 MOI100% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_682ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay0.5 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_683ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineA3751.0E+5 cells per wellNAMTT assay1 MOI50% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_684ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_685ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.01 MOI105% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_686ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.1 MOI77% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_687ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay0.5 MOI50% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_688ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineDO41.0E+5 cells per wellNAMTT assay1 MOI30% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_689ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_690ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.01 MOI126% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_691ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.1 MOI92% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_692ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay0.5 MOI72% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_693ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman melanoma cell lineMeWo1.0E+5 cells per wellNAMTT assay1 MOI61% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_694ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.001 MOI120% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_695ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.01 MOI105% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_696ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.1 MOI110% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_697ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay0.5 MOI99% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_698ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman malignant melanoma cell lineMel6241.0E+5 cells per wellNAMTT assay1 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_699ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.001 MOI108% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_700ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.01 MOI90% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_701ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.1 MOI100% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_702ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay0.5 MOI85% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_703ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell lineWM1791c1.0E+5 cells per wellNAMTT assay1 MOI92% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_704ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.001 MOI110% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_705ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.01 MOI92% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_706ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.1 MOI70% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_707ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay0.5 MOI25% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_708ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoProf. Richard Marais labHuman cutaneous melanoma cell linePMWK1.0E+5 cells per wellNAMTT assay1 MOI19% cancer cell viability (calculated as relative to non-infected group)NoNoNA No responseNADown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 9/3NANA27384486
OV_709ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoNANANANANANANANAXenograft female CD1 nude mice subcutaneously injected with 3.0E+6 A375 cells1.0E+6 pfu/mlNA %volume change is 400 as compared to control 700 after 40 daysIntratumoralDown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 3NANA27384486
OV_710ReovirusRT3D (Reolysin)RNAReoviridaeNoneNoViral strain in combination with radiation, 2 Gy for 3 cyclesNoNANANANANANANANAXenograft female CD1 nude mice subcutaneously injected with 3.0E+6 A375 cells1.0E+6 pfu/mlNA %volume change is 100 as compared to control 700 after 40 daysIntratumoralDown-regulation of the inhibitor of apoptosis (IAP) family of proteins with a corresponding increase in cleaved caspase 3NANA27384486
OV_711ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoATCCNANANANANANANAC57Bl/6j mice subcutaneously injected with 5.0E+5 B16F10 cells1.0E+7 PFU to 1.0E+9 PFU for three weeksNA 77% survived till 30 days (Reduction in tumor volume to 0.15 cubic centimeter compared to control 0.9 cubic centimeter after 15 days)intravenouslyNAUp-regulation of IL-12, IL-5, IL-10, TNF-alphaNA27412241
OV_712ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoATCCNANANANANANANAC57Bl/6j mice subcutaneously injected with 2.0E+5 LLC cells1.0E+7 PFU to 1.0E+9 PFU for three weeksNA 80% survived till 40 days (Reduction in tumor volume to 0.3 cubic centimeter compared to control 1.0 cubic centimeter after 20 days)intravenouslyNAUp-regulation of IFN-gammaNA27412241
OV_713ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoATCCNANANANANANANAC57Bl/6j mice subcutaneously injected with 5.0E+5 B16F10 cells (vaccinated with cell-based Reovirus vaccine 8–12 weeks prior to day 0)1.0E+7 PFU to 1.0E+9 PFU for three weeksNA 100% survived till 150 days (Reduction in tumor volume to 0.0 cubic centimeter compared to control 1.4 cubic centimeter after 16 days)intravenouslyNAUp-regulation of IL-12, IL-5, IL-10, TNF-alphaNA27412241
OV_714ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoATCCNANANANANANANAC57Bl/6j mice subcutaneously injected with 2.0E+5 LLC cells (vaccinated with cell-based Reovirus vaccine 8–12 weeks prior to day 0)1.0E+7 PFU to 1.0E+9 PFU for three weeksNA 100% survived till 200 days (Reduction in tumor volume to 0.0 cubic centimeter compared to control 1.3 cubic centimeter after 11 days)intravenouslyNAUp-regulation of IFN-gammaNA27412241
OV_715ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoATCCNANANANANANANAC57Bl/6j mice subcutaneously injected with 5.0E+5 B16F10 cells (prior single dose of cell-based reovirus vaccine for the treatment of established tumours)2.0E+7 PFU to 1.0E+9 PFU for three weeksNA 77% survived till 44 days (Reduction in tumor volume to 0.1 cubic centimeter compared to control 1.2 cubic centimeter after 16 days)intravenouslyNAUp-regulation of IL-12, IL-5, IL-10, TNF-alphaNA27412241
OV_716ReovirusRT3D (Reolysin)RNAReoviridaeNoneYesNoNoATCCNANANANANANANAC57Bl/6j mice subcutaneously injected with 2.0E+5 LLC cells (prior single dose of cell-based reovirus vaccine for the treatment of established tumours)3.0E+7 PFU to 1.0E+9 PFU for three weeksNA 60% survived till 52 days (Reduction in tumor volume to 0.14 cubic centimeter compared to control 21 cubic centimeter after 15 days)intravenouslyNAUp-regulation of IFN-gammaNA27412241
OV_1121Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm0.01MOI50% cell viablityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641
OV_1122Reoviruswild typeRNAReoviridaeNoneYesNoNoATCCCervical cancer cell lineHeLaS31.0E+5 cells per wellNAFluoroscent mesure at 450nm0.1MOI30% cell viabilityNoNoNA No responseApoptosis induction in cancer cell linesNANA15958641